2022-03-01 ⟩ Our strategic partner for personalized 3D printed healthcare applications, Kumovis, is joining forces with the US-based company 3D Systems through a 100% acquisition. RENOLIT Healthcare is happy to have been Kumovis’ first strategic partner in 2020 and to have successfully cooperated on some important projects like the filament production for 3D printing and the precision injection moulding, focusing on implantable medical devices since then.

True to our tagline “Together Towards Health”, the RENOLIT Group and the strategic market unit RENOLIT Healthcare are looking very much forward to a good future cooperation with Kumovis, further developing the 3D filament business and wish the team all the best for their future journey.

To read more about the sale of Kumovis’ shares to 3D Systems, please head over to this RENOLIT Group news and this 3D Systems press release.

If you are a healthcare startup and are looking for an open innovation partnership with experienced polymer parents, then send an email to healthcare@renolit.com. We are enjoying the cooperation with Kumovis and other startups so much that we are actively seeking new partners to bring healthcare to the next level.